EMA Grants Conditional Approval Of Pixuvri For B-Cell Lymphoma Wall Street Journal -Conditional approval will be renewed on a yearly basis until the obligation to provide additional data on rituximab-pretreated patients has been fulfilled. -Applicant, CTI Life Sciences Ltd., has informed the Committee that it expects to be able to ... European Medicines Agency's Committee For Medicinal Products For Human Use ... |
